mr DAVID ADLER

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC)

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for FY 2026 and FY2027 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding Support for report language encouraging NIH to support research into functional radiation medicine

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC)

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2025 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC)

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2025 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations Support for H.R. 8412, a bill to remove barriers to accessing clinical trials for underrepresented populations

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations Support for H.R. 8412, a bill to remove barriers to accessing clinical trials for underrepresented populations

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal years 2024 and 2025 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal years 2024 and 2025 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates by supporting H.R. 3674 to provide relief and stability in Medicare payments Support for H.R. 1202 for resident education deferred interest Support for H.R. 2474 to add inflationary updates to the MPFS Support for H.R. 2761 to defer loan payments for specialty physicians in rural areas Support for H.R. 6683, to fix the Medicare Physician Fee Schedule physician payment reimbursement cut Support H.R. 6800, a bill to increase pay cap for therapeutic medical physicists of the Department of Veterans Affairs

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates by supporting H.R. 3674 to provide relief and stability in Medicare payments Support for H.R. 1202 for resident education deferred interest Support for H.R. 2474 to add inflationary updates to the MPFS Support for H.R. 2761 to defer loan payments for specialty physicians in rural areas Support for H.R. 6683, to fix the Medicare Physician Fee Schedule physician payment reimbursement cut Support H.R. 6800, a bill to increase pay cap for therapeutic medical physicists of the Department of Veterans Affairs

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates by supporting H.R. 3674 to provide relief and stability in Medicare payments Support for H.R. 1202 for resident education deferred interest Support for H.R. 2474 to add inflationary updates to the MPFS Support for H.R. 2761 to defer loan payments for specialty physicians in rural areas

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 1202 for resident education deferred interest Support for H.R. 2474 to add inflationary updates to the MPFS Support for H.R. 2761 to defer loan payments for specialty physicians in rural areas

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 1202 for resident education deferred interest

FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

FY2023 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Oppose restrictive prior authorization practices Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for reforms to the CMMI proposed radiation oncology alternative payment model Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

Oppose restrictive prior authorization practices Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for reforms to the CMMI proposed radiation oncology alternative payment model Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 7995 Support for H.R. 8800

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

FY2023 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patients care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to education legislators about unintended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2022 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments Support for DIVERSE Trials Act to increase diversity in clinical trials Support for DOD lung cancer research program funding

Oppose restrictive prior authorization practices Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for reforms to the CMMI proposed radiation oncology alternative payment model Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 7995 Support for H.R. 8800

Oppose restrictive prior authorization practices Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for reforms to the CMMI proposed radiation oncology alternative payment model Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates

FY2022 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patients care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to education legislators about un-untended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

FY2022 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patients care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to education legislators about un-untended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Support for advancing health equity and eliminating health care disparities Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

FY2022 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patients care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to education legislators about un-untended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Economic relief for 501c6 organizations Support for advancing health equity and eliminating health care disparities

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery Support access to radioactive isotopes

Oppose restrictive prior authorization practices Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for reforms to the CMMI proposed radiation oncology alternative payment model Support for waiving budget neutrality adjustments with evaluation and management code changes Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2022 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2022 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments

FY2022 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patients care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride Support for NRC Commissioner nominee to have medical background Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Legislation to increase transparency in the prior authorization process Efforts to education legislators about un-untended consequences associated with rate setting for health care services Curb surprise billing for patients Preserve current training and experience requirements for radiopharmaceuticals Economic relief for 501c6 organizations Support for advancing health equity and eliminating health care disparities

Oppose restrictive prior authorization practices Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for reforms to the CMMI proposed radiation oncology alternative payment model Support for waiving budget neutrality adjustments with evaluation and management code changes

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2022 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved Cancer Moonshot Initiative Support for ARPA-H to support innovative cancer treatments

The Resident Education Deferred Interest Act (HR 1554) FY2020 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2143) Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico Legislation to increase transparency in the prior authorization process Efforts to educate legislators about un-intended consequences associated with rate setting for health care services HR 1966 Henrietta Lacks Enhancing Cancer Research Act of 2019 HR3107 Improving Seniors timely access to care act Curb surprise billing for patients preserve current training and experience requirements for radiopharmaceuticals H.R.748 CARES Act S.3548 CARES Act H.R.6201 Families First Coronavirus Response Act H.R.6074 Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 Economic relief for 501c6 organizations HR 5924 - Encourages specialty medicine physicians to serve in rural communities experiencing shortages of specialists. H.R.7255 - Coronavirus Health Care Worker Wellness Act of 2020- To authorize the Secretary of Health and Human Services to award grants to health care providers to establish or expand programs dedicated to promoting mental wellness among their health care workers, including contractors, on the front lines of the SARS-CoV-2 pandemic, and for other purposes.

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance. Support for waiving budget neutrality adjustments associated with evaluation and management code changes.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2020. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative S. 3203 - Therapeutic Medical Physicists Pay Cap Legislation

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2020. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative S. 3203 - Therapeutic Medical Physicists Pay Cap Legislation

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance. Support for waiving budget neutrality adjustments associated with evaluation and management code changes.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model S.3230 - TA SUPPORT Act to ensure that small and rural physician practices participating in Medicares new Merit-Based Incentive Payment System (MIPS) have access to the technical assistance.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2020. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative S. 3203 - Therapeutic Medical Physicists Pay Cap Legislation

The Resident Education Deferred Interest Act (HR 1554) FY2020 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2143) Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico Legislation to increase transparency in the prior authorization process Efforts to educate legislators about un-intended consequences associated with rate setting for health care services HR 1966 Henrietta Lacks Enhancing Cancer Research Act of 2019 HR3107 Improving Seniors timely access to care act Curb surprise billing for patients preserve current training and experience requirements for radiopharmaceuticals H.R.748 CARES Act S.3548 CARES Act H.R.6201 Families First Coronavirus Response Act H.R.6074 Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 Economic relief for 501c6 organizations

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

The Resident Education Deferred Interest Act (HR 1554) FY2020 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2143) Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico Legislation to increase transparency in the prior authorization process Efforts to educate legislators about un-intended consequences associated with rate setting for health care services HR 1966 Henrietta Lacks Enhancing Cancer Research Act of 2019 HR3107 Improving Seniors timely access to care act Curb surprise billing for patients

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2020. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2020. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

HR 913, Clinical Treatment Act Local Coverage Determinations Clarification Act Oppose restrictive prior authorization practices. S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law. for radiation therapy services; Promoting Integrity in Medicare Act (H.R. 2143) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare. sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support for reforms to the CMMI Proposed Radiation Oncology Alternative Payment Model

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2020. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes. Support for H.R.4675 - Low-Dose Radiation Research Act of 2017

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes. Support for H.R.4675 - Low-Dose Radiation Research Act of 2017

The Resident Education Deferred Interest Act (HR 1554) FY2020 LHHS Appropriations bill-funding for NIH/NCI HR 4675, Low Dose Radiation Research Act Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2143) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico

HR 6836, Clinical Treatment Act HR 3635, Local Coverage Determinations Act Prior Authorization S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to freeze radiation therapy payments through the end of 2019, increase funding for the NIH for FY 2018 and FY 2019, and simplify the MIPS program; Balanced Budget Act of 2018 (HR 1892). Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services; Protecting Integrity in Medicare Act (H.R. 2066) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services. S. 794 Local Coverage Determination Clarification Act of 2017

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2018 and 2019. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for 21st Century Cures Act Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes. Support for H.R.4675 - Low-Dose Radiation Research Act of 2017

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2018 and 2019. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for 21st Century Cures Act Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2018 and 2019. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for 21st Century Cures Act Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes. Support for H.R.4675 - Low-Dose Radiation Research Act of 2017

S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to freeze radiation therapy payments through the end of 2019, increase funding for the NIH for FY 2018 and FY 2019, and simplify the MIPS program; Balanced Budget Act of 2018 (HR 1892). Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services; Protecting Integrity in Medicare Act (H.R. 2066) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services. S. 794 Local Coverage Determination Clarification Act of 2017

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2018 and 2019. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for 21st Century Cures Act Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes. Support for H.R.4675 - Low-Dose Radiation Research Act of 2017

Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2017 and 2018. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for 21st Century Cures Act Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services; Protecting Integrity in Medicare Act (H.R. 2066) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services. S. 794 Local Coverage Determination Clarification Act of 2017

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2017 and 2018. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for 21st Century Cures Act Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery. Support access to radioactive isotopes.

S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services; Protecting Integrity in Medicare Act (H.R. 2066) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services. S. 794 Local Coverage Determination Clarification Act of 2017

Support for a national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. FDA review process of medical devices; The Medical Device Guardians Act of 2016 (H.R. 5404) Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 5088) Oppose Non-Burning Sunshine Report Language Oppose HR 2698, Tanning Tax Repeal Act of 2015 Support HR 239, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative H.R. 5721 Local Coverage Determination Clarification Act of 2016

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2016 and 2017. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2016 and 2017. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Cancer Moonshot Initiative

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services; Protecting Integrity in Medicare Act (H.R. 5088) Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services. S. 1549, To amend title XVIII of the Social Security Act to provide for advanced illness care coordination services for Medicare beneficiaries, and for other purposes. Helping Hospitals Improve Patient Care (H.R. 5273)

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

S.2425-Patient Access and Medicare Protection Act (PAMPA) implementation. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Implementation of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule. Support for legislation to ensure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2014 and 2015. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Support for H. Con Res 27 and S. Con Res 11, Establishing the budget for the U.S. Government for FY2016

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2014 and 2015. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for increased and sustained funding for the Graduation Medical Education program to support residency programs crucial for training the next generation of doctors treating cancer patients. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved. Support for H. Con Res 27 and S. Con Res 11, Establishing the budget for the U.S. Government for FY2016

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule. Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015 Support the elimination of abuse to the Medicare program by closing the in-office ancillary services exception to the Stark Law for radiation oncology services.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy.Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for coverage of routine patient care costs incurred when individuals enroll in clinical trials for the prevention, detection, or treatment of cancer and other life-threatening diseases. Support for legislation to ensure that government employees are able to attend educational meetings and conferences hosted by trade associations in their respective field, without compromising Congresss goal of enhanced federal accountability. Support for setting standards for essential health benefits, actuarial value and accreditation to better foster a cancer care system that balances access to comprehensive care and affordability. Support for NRC Commissioner nominee to have medical background.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radio surgery.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2013 and 2014. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute.Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for preserving critical GME funding to support residency programs crucial for training the next generation of doctors treating cancer patients nationwide. Support for legislation to increase the number of Medicare-supported training positions for medical residents. Ensure that radiological materials used for the diagnosis and treatment of patients are secured and access to care preserved.

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy.Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for coverage of routine patient care costs incurred when individuals enroll in clinical trials for the prevention, detection, or treatment of cancer and other life-threatening diseases. Support for legislation to ensure that government employees are able to attend educational meetings and conferences hosted by trade associations in their respective field, without compromising Congresss goal of enhanced federal accountability. Support for setting standards for essential health benefits, actuarial value and accreditation to better foster a cancer care system that balances access to comprehensive care and affordability.

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 1146). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011 Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2914, Promoting Integrity in Medicare Act of 2013, which amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship. Support for H.R. 2810, the Medicare Patient Access and Quality Improvement Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to: (1) repeal sustainable growth rate (SGR) methodology from the determination of annual conversion factors in the formula for payment for physicians' services; and (2) prescribe an update to the single conversion factor for 2014 through 2018, as well as 2019 all subsequent years, of 0.5%. Support the SGR repeal and Medicare Beneficiary Access Improvement Act of 2013

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2013 and 2014. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute.Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy.Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for coverage of routine patient care costs incurred when individuals enroll in clinical trials for the prevention, detection, or treatment of cancer and other life-threatening diseases. Support for legislation to ensure that government employees are able to attend educational meetings and conferences hosted by trade associations in their respective field, without compromising Congresss goal of enhanced federal accountability. Support for setting standards for essential health benefits, actuarial value and accreditation to better foster a cancer care system that balances access to comprehensive care and affordability. Support for improving the methods and timeliness of notice regarding drug shortages, identifying and assessing alternative manufacturing sites and entities for drugs and biologicals in shortage situation, and developing strategies to assess and address the impact of shortages on clinical trials. Support regulations to make patient-specific clinical trials data available for additional research purposes. Support for the Federally-facilitated Marketplace (FFM) and the standards for certification of health plans as qualified health plans (QHP) have been modified from 2014 in a manner that is responsive to the needs of individuals with cancer and other serious and life-threatening illnesses.

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2013 and 2014. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute.Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 1146). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011 Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2477, the Planning Actively for Cancer Treatment (PACT) Act, to establish a new Medicare service for cancer care planning and coordination. Support for H.R. 2914, Promoting Integrity in Medicare Act of 2013, which amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship. Support for H.R. 2810, the Medicare Patient Access and Quality Improvement Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to: (1) repeal sustainable growth rate (SGR) methodology from the determination of annual conversion factors in the formula for payment for physicians' services; and (2) prescribe an update to the single conversion factor for 2014 through 2018, as well as 2019 all subsequent years, of 0.5%. Support the SGR repeal and Medicare Beneficiary Access Improvement Act of 2013

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy.Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for coverage of routine patient care costs incurred when individuals enroll in clinical trials for the prevention, detection, or treatment of cancer and other life-threatening diseases. Support for legislation to ensure that government employees are able to attend educational meetings and conferences hosted by trade associations in their respective field, without compromising Congresss goal of enhanced federal accountability. Support for setting standards for essential health benefits, actuarial value and accreditation to better foster a cancer care system that balances access to comprehensive care and affordability. Support for improving the methods and timeliness of notice regarding drug shortages, identifying and assessing alternative manufacturing sites and entities for drugs and biologicals in shortage situation, and developing strategies to assess and address the impact of shortages on clinical trials.

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2013 and 2014. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute.Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy.Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for coverage of routine patient care costs incurred when individuals enroll in clinical trials for the prevention, detection, or treatment of cancer and other life-threatening diseases. Support for legislation to ensure that government employees are able to attend educational meetings and conferences hosted by trade associations in their respective field, without compromising Congresss goal of enhanced federal accountability. Support for setting standards for essential health benefits, actuarial value and accreditation to better foster a cancer care system that balances access to comprehensive care and affordability. Support for improving the methods and timeliness of notice regarding drug shortages, identifying and assessing alternative manufacturing sites and entities for drugs and biologicals in shortage situation, and developing strategies to assess and address the impact of shortages on clinical trials.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2013 and 2014. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute.Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2013 and 2014. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute.Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 1146). Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452) (S 2118). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 2104). Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452) (S 2118). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Research of legislation to exempt certain requests by physicians for consultations by radiation oncologists (HR 4127). Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery. Support the development of domestic isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99).

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 2104). Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452) (S 2118). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Research of legislation to exempt certain requests by physicians for consultations by radiation oncologists (HR 4127). Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations. Support for pediatric cancer research, including the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA).

Support for protecting access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery. Support the development of domestic isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99).

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 2104). Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452) (S 2118). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Research of legislation to exempt certain requests by physicians for consultations by radiation oncologists (HR 4127).

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 2104). Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452) (S 2118). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Research of legislation to exempt certain requests by physicians for consultations by radiation oncologists (HR 4127).

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012. Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute. Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations.

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99). Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support to update the operation of the 510(k) program and the way Center for Devices and Radiological Health (CDRH) uses science in its decision making process. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for setting conditions for lawsuits arising from health care liability claims, specifically the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 (H.R. 5).

To protect access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery. Development of domestic isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99).

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012.

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for setting conditions for lawsuits arising from health care liability claims, specifically the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 (H.R. 5). Support coverage of routine patient care costs incurred when individuals enroll in clinical trials for the prevention, detection, or treatment of cancer and other life-threatening diseases.

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

Support legislation to increase the budget for the National Institutes of Health and the Centers for Disease Control and Prevention for fiscal year 2011 and 2012.

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for setting conditions for lawsuits arising from health care liability claims, specifically the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 (H.R. 5).

Support for lifting the salary cap on medical physicists at Veterans Affairs radiation oncology service centers.

To protect access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery. Development of domestic isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99).

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support modifications to the FDA review process of medical devices to consider interoperability issues. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for setting conditions for lawsuits arising from health care liability claims, specifically the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 (H.R. 5).

To protect access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery. Development of domestic isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99).

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2011 (S. 99). Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support to update the operation of the 510(k) program and the way Center for Devices and Radiological Health (CDRH) uses science in its decision making process. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148). Support for setting conditions for lawsuits arising from health care liability claims, specifically the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 (H.R. 5).

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy.Support for the development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2010 (H.R. 3276). Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support to ensure that patient care and advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support to update the operation of the 510(k) program and the way Center for Devices and Radiological Health (CDRH) uses science in its decision making process. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148).

To protect access to medical isotopes used in cancer treatments such as brachytherapy and sterotactic radiosurgery. Development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2010 (H.R. 3276).

Support for the Veterans' Health and Radiation Safety Act (H.R. 4062) to ensure oversight of radiation oncology procedures are carried out in an effective and efficient manner while maintaining patient safety.

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Medicare and Medicaid Extenders Act of 2010 (H.R. 4994) to avoid a 25 percent cut to physicians' Medicare payments in 2012. Support for Comprehensive Cancer Care Improvement Act of 2009 (H.R.1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Support for Medicare Cancer Patient Database and Coverage Act of 2009 (H.R. 3095) to provide Medicare coverage for cancer patients. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2010 (S. 3737, H.R. 3652).

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2010 (H.R. 3276). Support efforts to raise awareness of nuclear safety culture issues and to improve safety in the medical use of radioactive materials and in all aspects of radiation use. Support to ensure that patient care and advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support to update the operation of the 510(k) program and the way Center for Devices and Radiological Health (CDRH) uses science in its decision making process. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148).

Support for the Veterans' Health and Radiation Safety Act (H.R. 4062) to ensure oversight of radiation oncology procedures are carried out in an effective and efficient manner while maintaining patient safety.

Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2010 (H.R. 3276). Support to update the operation of the 510(k) program and the way Center for Devices and Radiological Health (CDRH) uses science in its decision making process. Support for implementation of patient protection and insurance expansions from the Patient Protection and Affordable Care Act (PL No: 111-148).

Support for Fiscal 2011 Labor-HHS-Education Appropriations (S. 3686, H.R. 3293) to increase the budget for the National Institutes of Health.

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments, including support for the Medicare Physician Fairness Act of 2009 (S. 1776) and the Medicare Physician Payment Reform Act (H.R. 3961). Support for American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213) to delay a 21% cut to physicians' Medicare paymentsuntil 2012. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Comprehensive Cancer Care Improvement Act of 2009 (H.R. 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Medicare Cancer Patient Database and Coverage Act of 2009 (H.R. 3095) to provide Medicare coverage for cancer patients. Support for the Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2009 (H.R. 3652) for the credentialing of radiation therapy technologists.

Support for the Veterans' Health and Radiation Safety Act (H.R. 4062) to ensure oversight of radiation oncology procedures are carried out in an effective and efficient manner while maintaining patient safety.

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments, including support for the Medicare Physician Fairness Act of 2009 (S. 1776) and the Medicare Physician Payment Reform Act (H.R. 3961). Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Comprehensive Cancer Care Improvement Act of 2009 (H.R. 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Medicare Cancer Patient Database and Coverage Act of 2009 (H.R. 3095) to provide Medicare coverage for cancer patients. Oppose Gregg amendment to health care reform requiring public reporting of quality data. Support for the Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2009 (H.R. 3652) for the credentialing of radiation therapy technologists.

To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery. Development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2010 (H.R. 3276).

To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery. Development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2010 (H.R. 3276).

Support for increasing cancer research funding, including support for the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 (H.R. 3293); oppose Sessions-McCaskill amendment to establish discretionary spending caps for NCI.

Support for the Veterans' Health and Radiation Safety Act (H.R. 4062) to ensure oversight of radiation oncology procedures are carried out in an effective and efficient manner while maintaining patient safety.

Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200), the Patient Protection and Affordable Care Act (H.R. 3590), and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2009 (H.R. 3276). Letter to FDA supporting regulation to ensure the validity of in vitro diagnostic tests.

Review of brachytherapy treatments at Philadelphia VA and testimony to promote brachytherapy as a safe cancer treatment option. Support for the Veterans' Health and Radiation Safety Act (H.R. 4062) to ensure oversight of radiation oncology procedures are carried out in an effective and efficient manner while maintaining patient safety.

Review of brachytherapy treatments at Philadelphia VA and testimony to promote brachytherapy as a safe cancer treatment option.

Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for the 21st Century Cancer ALERT bill (S. 717) to modernize cancer research, increase access to preventative cancer services, provide cancer treatment and survivorship initiatives, and for other purposes. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200) and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support funding for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2009 (H.R. 3276). Support for increasing cancer research funding, including support for the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 (H.R. 3293).

To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery. Development of domestic medical isotope production.

Support for legislation to reform the Medicare physician payment formulat to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for H.R. 3095 to provide Medicare coverage for cancer patients. Comprehensive Cancer Care Improvement Act of 2009 (HR 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Legislation to support structural changes that lead to deliverying high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for S1213 to provide funding for comparative effectiveness research.

Support for legislation to reform the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Comprehensive Cancer Care Improvement Act of 2009 (HR 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Legislation to support structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability.

SConRes 70 / HConRes 321, S 3230 (Labor-HHS Appropriations) regarding the appropriations allocation for the National Institutes of Health (NIH) and the National Cancer Institute (NCI); allocation for the implementation of the Nurse Reinvestment Act and other nursing workforce development programs at the Health Resources and Service Administration (HRSA); funding for the Dept. of Energy's nuclear medicine research and medical applications program HR 2642 (Supplemental Appropriations Act of 2008) and the economic stimulus legislation (American Recovery and Reinvestment Act) regarding increased funding for NIH and NCI

HR 3014 (Health Equity and Accountability Act of 2007) to expand culturally and linguistically appropriate health care service and to address racial and ethnic disparities. Legislation to reform health care through a combination of public and private approaches to cover medically necessary services. HR 6791 (National Cancer Fund Act of 2008) to increase federal taxes on tobacco products and dedicate these revenues to increased cancer research funding. Anticipated legislation from Senators Kennedy and Hutchinson to address unique cancer needs of patients and to renew and revive programs to cure cancer.

HR 3014 (Health Equity and Accountability Act of 2007) to expand culturally and linguistically appropriate health care services and to address racial and ethnic disparities. Legislation to reform health care though a combination of public and private approaches to cover medically necessary services. HR 493 (Genetic Information Nondiscrimination Act of 2007)- prevents employers and insurers from collecting genetic data about their employees or patients or using the information in business decisions such as hiring and firing, enrollment, or setting insurance premiums. Anticipated legislation from Senators Kennedy and Hutchinson to address unique cancer needs of patients and to renew and revive program to cure cancer.

HR 3014- "Health Equity and Accountability Act of 2007" to expand culturally and linguistically appropriate health care services and to address racial and ethnic disparities Health care reform through a combination of public and private approaches to cover medically necessary services.

HR 493/S 358, Genetic Information Nondiscrimination Act of 2007 re: protection of patient's genetic information and prohibiting discrimination against patients based on that information.

HR 3/S 5, Stem Cell Research Enhancement Act of 2007